20% off your first orderAutomatically applied at checkout

Preparation & Measurement Guide

Selank 11mg Dosage Protocol

Preparation, measurement, commonly documented protocol ranges, and storage for a Selank 11mg vial.

Research use only Educational summary of a commonly documented convention. Not approved for human use.
Vial Size Selank 11mg
Preparation 2mL bacteriostatic water
Concentration 5.5mg/mL after preparation
Documented Convention 300-500mcg once daily

1. Preparation and Measurement

Selank 11mg With 2mL of Diluent

Add 2mL of bacteriostatic water to the vial. The resulting concentration is 5.5mg/mL. On a U-100 syringe, each unit contains 55mcg.

11mg / 2mL = 5.5mg/mL
1 U-100 unit = 0.01mL = 55mcg

Preparation

  1. Draw 2mL of bacteriostatic water using sterile equipment.
  2. Let the liquid run slowly down the inside wall of the vial.
  3. Gently swirl until dissolved. Do not shake.
  4. Label with the preparation date and refrigerate.

Check the calculation with the peptide calculator.

2. Commonly Documented Schedule

Route commonly described: subcutaneous in circulated vial protocols. Frequency: once daily.

Period Documented amount Measurement
Weeks 1-2 300mcg once daily 0.055mL / 5.5 units
Weeks 3-4 500mcg once daily 0.091mL / 9.1 units

Vial estimate: One 11mg vial contains approximately 36 complete 300mcg portions or 22 complete 500mcg portions before handling loss.

Practical Notes

  • The table applies only to this vial prepared with exactly 2mL.
  • Record the amount, date, and preparation used.

3. Supplies Needed

  • Selank 11mg vial.
  • 2mL of bacteriostatic water per vial.
  • Sterile U-100 syringes.
  • Alcohol swabs.
  • Sharps container.

4. Storage and Handling

  • Keep unopened vials cool, dry, dark, and protected from moisture.
  • After preparation, refrigerate at 2-8 degrees C.
  • Protect from light and avoid repeated freeze-thaw cycles.
  • Do not use material with particles, discoloration, or a damaged seal.

5. Research Context

Selank has limited human literature and additional animal work involving anxiety-related measures and GABAergic signalling. Some clinical literature used intranasal formulations, so it does not validate a reconstituted vial convention.

Selank is not an approved therapeutic drug in Canada or the United States. The table is an educational record of a circulated convention.

Primary Research and Regulatory References

  1. Selank generalized-anxiety clinical comparison
  2. Selank and GABAergic gene-expression study

Research Materials

Review Selank 11mg Product Information

← Back to Dosage Protocols

Research-use disclaimer: Selank 11mg products sold by Vialcrest are intended strictly for laboratory research. They are not intended for human consumption, injection, therapeutic use, medical use, diagnostic use, or veterinary use. This article documents how a commonly circulated or published convention is described for educational comparison. It does not endorse that convention, establish safety or efficacy, or provide medical advice.

Continue exploring

More Dosage Protocols

← Back to Dosage Protocols